Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88,283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.
Zhang X, Hong J, Zhong L, Wu Q, Zhang S, Zhu Q, Chen H, Wei D, Li R, Zhang W, Zhang X, Wang G, Zhou X, Chen J, Kang Y, Zha Z, Duan X, Huang Y, Sun C, Kong X, Zhou Y, Chen Y, Ye X, Feng Q, Li S, Xiang T, Gao S, Zeng MS, Zheng Q, Chen Y, Zeng YX, Xia N, Xu M. Zhang X, et al. Among authors: chen j, chen h, chen y. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2202371119. doi: 10.1073/pnas.2202371119. Epub 2022 Aug 2. Proc Natl Acad Sci U S A. 2022. PMID: 35917353 Free PMC article.
T cell epitope screening of Epstein-Barr virus fusion protein gB.
Chen H, Zhang X, Zhang S, Duan X, Xiang T, Zhou X, Zhang W, Zhang X, Feng Q, Kang Y, Li J, Deng L, Wang L, Lv X, Zeng M, Zeng YX, Xu M. Chen H, et al. J Virol. 2021 Apr 26;95(10):e00081-21. doi: 10.1128/JVI.00081-21. Epub 2021 Mar 3. J Virol. 2021. PMID: 33658348 Free PMC article.
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.
Hong J, Zhong L, Zheng Q, Wu Q, Zha Z, Wei D, Chen H, Zhang W, Zhang S, Huang Y, Chen K, Chen J, Li S, Zeng MS, Zeng YX, Xia N, Zhang X, Xu M, Chen Y. Hong J, et al. Among authors: chen j, chen k, chen h, chen y. J Virol. 2022 Apr 27;96(8):e0007522. doi: 10.1128/jvi.00075-22. Epub 2022 Mar 29. J Virol. 2022. PMID: 35348362 Free PMC article.
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China.
Li Q, Zhou Q, Zhao S, Wu P, Shi P, Zeng J, Xiong X, Chen H, Kittaneh M, Bravaccini S, Zanoni M, Zhou C, Zhang J. Li Q, et al. Among authors: chen h. Transl Lung Cancer Res. 2022 Oct;11(10):2136-2147. doi: 10.21037/tlcr-22-655. Transl Lung Cancer Res. 2022. PMID: 36386464 Free PMC article.
88,283 results
You have reached the last available page of results. Please see the User Guide for more information.